It was recently reported in the rat that vardenafil given in a continuous long-term manner was successful in preventing smooth muscle fibrosis in the penile corpora cavernosa and corporal venoocclusive dysfunction (CVOD) that occur following bilateral cavernosal nerve resection (BCNR), a model for human erectile dysfunction after radical prostatectomy. To expand on this finding and to determine whether this effect was common to other PDE5 inhibitors, and occurred in part by stimulation of the spontaneous induction of inducible nitric oxide synthase (iNOS, also known as NOS2), male Fischer 344 rats (N ¼ 10/group) were subjected to either BCNR or unilateral cavernosal nerve resection (UCNR) and treated with sildenafil (20 mg kg À1 day
Introduction
Erectile dysfunction is a common complication following radical prostatectomy that affects the quality of life of both the patient and his partner. In addition, many men who have been diagnosed with early stage prostate cancer and are candidates for radical prostatectomy avoid this surgery primarily because of the fear of developing this side effect. [1] [2] [3] The main cause of erectile dysfunction in this patient population is corporal veno-occlusive dysfunction (CVOD), which occurs when the corporal smooth muscle is unable to relax sufficiently and let the intracorporeal pressure adequately compress the subtunical veins, which prevents the egress of blood out of the corpora during tumescence. 4 Regardless of its cause, when the number of smooth muscle cells (SMC) decreases and/or the collagen content increases, the corporal tissue loses its normal compliance and is prone to developing CVOD.
During a radical prostatectomy, the cavernosal nerves are susceptible to injury. This not only impairs the normal nitrergic neurotransmission which initiates the normal erectile response, but can also lead to the loss of SMC and corporal fibrosis. [5] [6] [7] [8] It is this alteration in the corporal smooth muscle to collagen ratio that is assumed to lead to CVOD. 9 As a result, both spontaneous erections and the response to vasoactive drugs, including the oral PDE5 inhibitors when given on demand to elicit an erection, can be adversely affected. 3, 10 Several recent studies addressing CVOD in the aged or diabetic rat suggests that this form of erectile dysfunction is associated with the loss of SMC and excessive deposition of collagen fibers within the corpora, and that the long-term continuous administration of PDE5 inhibitors may counteract these processes. [11] [12] [13] It is likely that this occurs through the maintenance of high levels of cGMP, since this compound reduces collagen synthesis and the activation of the pro-fibrotic TGFb1 pathway and protects SMC from apoptosis, while stimulating the spontaneous induction of inducible nitric oxide synthase (iNOS, also known as NOS2). [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] The expression of iNOS in certain non-immunological tissues is assumed to be a defense mechanism against fibrosis. [24] [25] [26] [27] [28] [29] The nitric oxide produced by iNOS, besides inhibiting collagen synthesis and the TGFb1 pathway, also quenches reactive oxygen species, and in some cases, the differentiation of fibroblasts to myofibroblasts, the cells that produce collagen in many fibrotic conditions. [30] [31] [32] In a recent study, we have shown that the PDE5 inhibitor, vardenafil, given for 45 days in the drinking water to rats subjected to bilateral cavernosal nerve resection (BCNR) [33] [34] [35] prevented the development of CVOD and the underlying SMC loss and fibrosis in the corpora cavernosa. 36 An antifibrotic effect by vardenafil and sildenafil was observed in the penile tunica albuginea in the rat model of Peyronie's disease, and in the case of sildenafil in the aged corpora smooth muscle. 37, 38, 12 In order to confirm and expand those findings by studying not only BCNR, but also unilateral cavernosal nerve resection (UCNR), and by using another PDE5 inhibitor, we have determined: (a) how a unilateral nerve injury compares to the more severe BCNR, and (b) whether sildenafil has similar anti-fibrotic properties as vardenafil and works via iNOS induction.
Materials and methods

Animal treatments
Five-month-old male Fisher 344 rats (Harlan Sprague-Dawley, San Diego, CA, USA) were treated with an IACUC-approved protocol, and divided as follows (n ¼ 10/group): A (sham-operated); B (UCNR), C (UCNR þ sildenafil), D (BCNR) and E (BCNR þ sildenafil). The drug was given in the drinking water for 45 days (water intake ad libitum). Nerve resection was performed as described. 33, 35, 36 In the sham-operated group, both cavernosal nerves were identified but not resected. In the other groups, the main cavernosal nerves were resected by removing a 3-mm segment uni-or bilaterally. Sildenafil (Pfizer Ltd, Sandwich, UK) was dissolved in the drinking water (0.3 mg ml À1 ), as described previously. 12 The drinking volume was determined daily, and the body weight was recorded weekly. The daily sildenafil dose (20 mg kg
À1
) was approximately equivalent to a single 200-mg tablet daily dose in men, when corrected for differences in total body surface area. 12, 38 Treated animals were switched to regular drinking water 1 day prior to cavernosometry, as a washout process. In a subsequent experiment, treatments for groups D and E were repeated, but receiving or not the inhibitor of iNOS activity L-N6-(1-iminoethyl)-lysine (L-NIL) in the drinking water at 100 mg l
(calculated dose:6.7 mg kg À1 day
) (n ¼ 8/group).
Dynamic infusion cavernosometry
It was performed as described. [11] [12] [13] In brief, the basal intracavernosal pressure (ICP) was recorded, and 2 mg papaverine was administered through a cannula into the corpora cavernosa. The ICP was recorded 5 min later as the 'ICP after papaverine'. After complete detumescence, saline was infused through another cannula, increasing the infusion rate by 0.05 ml min À1 every 10 s, until the ICP reached 100 mm Hg ('infusion rate'). Then the infusion was adjusted to hold the ICP around 100 mm Hg ('maintenance rate'). The 'drop rate' was determined by recording the decrease in ICP within the next 1 min after the infusion was stopped.
Histochemistry and immunohistochemistry
After cavernosometry, the rats were killed and the middle regions of the skin-denuded penile shafts were fixed overnight in 10% formalin, washed and stored in 70% alcohol at 4 1C until processed for paraffin-embedded tissue sectioning (5 mm). Adjacent sections were used for Masson's trichrome staining for collagen (blue) and SM (red); picrosirius red under polarized microscopy for collagen III (green and green-yellow)/I (red and orange) ratios; and immuno-detection with monoclonal antibodies against a-smooth muscle-actin (ASMA) as an SMC marker (Sigma Kit, Sigma Diagnostics, St Louis, MO, USA), proliferating cell nuclear antigen (PCNA) as a marker of cell proliferation (Chemicon, Temecula, CA, USA), and polyclonal antibodies against transforming growth factor b1 (TGFb1) (1:200; Promega, Madison, WI, USA) and iNOS (1:500; Calbiochem, La Jolla, CA, USA). 12, 37 The specificity of the antibodies was validated by western blot.
Cavernosal nerve damage and sildenafil I Kovanecz et al Sections were then incubated with biotinylated anti-mouse immunoglobulin G (IgG) for ASMA and PCNA or biotinylated anti-rabbit IgG for iNOS and TGFb1, followed by avidin-biotin complex (Vector Labs, Burlingame, CA, USA) and 3,3 0 diaminobenzidine (Sigma Chemical, St Louis, MO, USA) for PCNA and iNOS, or the ASMA Sigma Kit for ASMA and 3-amino-9-ethylcarbazole. The terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) assay was performed with the Apoptag peroxidase detection assay (Chemicon). The sections were counterstained with hematoxylin. The negative controls for immunohistochemistry were performed by replacing the first antibody with the IgG isotype. For the negative control for the TUNEL assay, buffer was substituted for the terminal deoxynucleotidyl transferase enzyme. Testicular sections from old animals were used as a positive control for TUNEL.
Quantitative image analysis
It was performed by computerized densitometry using the ImagePro Plus, version 5.1, program (Media Cybernetics, Silver Spring, MD, USA) coupled to an Olympus BHS microscope equipped with an Olympus digital camera. 12, 13 For Masson staining, Â 40 magnification pictures of the penis composed of one half of the corpora cavernosa but excluding the sinusoidal spaces were analyzed for SM (stained in red) and collagen (stained in blue) and expressed as the SM/collagen ratio. An identical approach was used for the collagen III/I ratios. For ASMA and iNOS staining, only the corpora cavernosa was analyzed in a computerized grid and expressed as the percentage of positive area versus total area of the corpora cavernosa. The intensity of immunostaining was determined as the percentage of integrated optical density in the corpora cavernosa. For the TGFb1, PCNA and TUNEL determinations, the number of positive cells at Â 400 was counted, and the results are expressed as the percentage of positive cells/total cells in the corpora cavernosa. In all cases, two fields at Â 40, or eight fields at Â 400, were analyzed per tissue section, with at least four matched sections per animal and 6-11 animals per group.
Quantitative western blots
Penile homogenates of frozen tissue (100 mg) were obtained in T-PER (PIERCE, Rockford, IL, USA) and protease inhibitors (3 mM leupeptin, 1 mM pepstatin A, 1 mM phenyl methyl sulfonyl fluoride), and centrifuged at 10 000 g for 5 min. Supernatant protein (30 mg) was run on 7.5 or 10% (ASMA) polyacrylamide gels, and submitted to western blot immunodetection with a monoclonal ASMA IgG (1:1000;Oncogene-Calbiochem, La Jolla, CA, USA), detecting a 43 kDa band. Membranes were incubated with a secondary polyclonal horse anti-mouse IgG linked to horseradish peroxidase (1:2000; BD Transduction Labs, San Diego, CA, USA), and bands were visualized with luminol (Pierce, Rockford, IL, USA).
12,38 A single positive control was run throughout all gels for each antibody to standardize for variations in exposures and staining intensities. Negative controls were performed omitting the primary antibody. Band intensities were determined by densitometry and corrected by the respective intensities for a housekeeping protein, glyceraldehyde phosphate dehydrogenase, upon reprobing.
Collagen estimation in fresh tissue
As previously described, the tissue was homogenized in saline, hydrolyzed with 2N NaOH for 30 min at 120 1C, followed by the estimation of hydroxyproline by a modification of the Neumann and Logan's reaction using Chloramine T and Ehrlich's reagent, against a hydroxyproline standard curve and measuring at 550 nm. [11] [12] [13] 38 Values were expressed as mg of collagen per mg of tissue.
Statistical analysis
The values are expressed as the mean7s.e.m. The normality distribution of the data was established using the Wilk-Shapiro test. Multiple comparisons were analyzed by a single factor analysis of variance, followed by post hoc comparisons with the Newman-Keuls test, according to the GraphPad Prism, version 4.1 for windows (GraphPad Software, San Diego CA, USA). Differences were considered significant at Po0.05.
Results
There was no significant difference in body weights between the groups. Sildenafil treatment did not cause priapism, lethargy, aggressiveness or any other noticeable side effect. Rats were subjected to cavernosometry after a 24 h washout period that reduces sildenafil concentrations to baseline. 12, 39 Rats undergoing UCNR and BCNR for 45 days had a significant increase in the drop rate as compared to sham-operated animals, which was higher after BCNR than UCNR (Figure 1 bottom) , and this was accompanied by a significant reduction of the response to papaverine (top), but only in the BCNR rats. This confirmed our previous observation that CVOD is induced by BCNR, and showed that UCNR induced a moderate CVOD.
14 Continuous oral treatment with sildenafil normalized the drop rate and response to papaverine (top and bottom) in both the UCNR and BCNR animals.
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The underlying changes in corporal histology reflected the cavernosometric findings in terms of the smooth muscle/collagen ratio, and SMC content as shown on the representative microphotographs of cross sections of the corpora cavernosa obtained from sham, BCNR untreated and BCNR treated rats, and stained by Masson trichrome or ASMA (Figure 2 top panels). The estimations were performed around the lacunar spaces area where the SMC are concentrated. Both BCNR and UCNR reduced the SMC to collagen ratio, as estimated by Masson trichrome and quantitative image analysis, by about 30% as compared to sham-operated rats, and this was prevented by sildenafil treatment in both the BCNR and UCNR animals (Figure 2 top graph) . That these changes in the ratio were due, at least partially, to absolute changes in the SMC content, was shown by quantitative immunohistochemistry for ASMA as a marker of SMC (Figure 2 bottom graph) . Both UCNR and BCNR reduced this SMC content by about 60%, at least directly around the lacunar spaces, and sildenafil increased it significantly, but did not fully normalize it.
SMC content was also evaluated in total corpora cavernosa homogenates of the BCNR specimens only, via ASMA immunodetection by quantitative western blot. These preparations of the homogenates include, in addition to corporal SMC, the SMC from the corpus spongiosum and the media of the corporal arteries as well as potential myofibroblasts in the tunica or interstitial connective tissue, whereas the immunohistochemical detection performed above is restricted to corporal SMC. The ASMA band was considerably increased by sildenafil treatment, in comparison to the untreated BCNR rats (Figure 3 top) , and the densitometric quantitation (Figure 3 
Collagen content and composition were both affected by nerve resection and by sildenafil treatment. The collagen content was significantly increased by BCNR, but not by UCNR when compared to the sham-operated animals (Figure 4 bottom graph) . Continuous long-term sildenafil treatment reduced the collagen content in the BCNR rats, but did not normalize this value. Both BCNR and UCNR decreased the collagen III/I ratio (Figure 4 top graph) as seen previously with vardenafil, although in the UCNR group, this did not reach statistical significance. Sildenafil normalized the collagen III/I ratio in the BCNR rats. 33 The reduction in SMC was accompanied by a nearly 3-fold increase in apoptosis induced by BCNR and UCNR ( Figure 5 top graph) , when compared to the sham-operated animals. The % apoptotic index was reduced to normal values in both BCNR and UCNR with continuous long-term sildenafil treatment. The levels of TGFb1, presumably involved in collagen deposition and SMC loss, were also increased by nearly 2-fold by both UCNR and BCNR ( Figure 5 bottom graph) , and restored to sham values with continuous long-term sildenafil treatment.
Cell replication within the corpora was evaluated by staining for PCNA (Figure 6 top graph) , showing that the % proliferation index was reduced 3-4-fold by UCNR and BCNR compared to sham-operated animals. Continuous long-term sildenafil treatment stimulated cell proliferation restoring the low values seen in the UCNR and BCNR groups back up to the values of the sham controls. As a result, the ratio between the cell proliferation and apoptosis, an indicator of cell turnover, was dramatically reduced by both UCNR and BCNR, and while this was counteracted by sildenafil, normal values were only restored in the UCNR animals.
iNOS, a putative anti-fibrotic and pro-apoptotic factor, was increased 3-4-fold in both the UCNR and BCNR rats when compared to the control animals, as shown by immunohistochemistry (Figure 7) . However, in the long-term sildenafil treated animals, which demonstrated a decrease in both fibrosis and apoptosis when compared to the non-sildenafil treated UCNR and BCNR animals, iNOS induction Cavernosal nerve damage and sildenafil I Kovanecz et al was not altered and remained elevated like those of the untreated UCNR and BCNR animals.
To determine whether iNOS spontaneous induction acts as an antifibrotic mechanism subsequent to cavernosal nerve damage, and whether it plays any role in the protection exerted by sildenafil, L-NIL was given to new groups of BCNR rats immediately after the intervention, and these animals were treated or not with sildenafil for 45 days. Other two similar groups did not receive L-NIL. Cavernosometry showed that in the BCNR rats the ICP after papaverine was reduced by L-NIL treatment to the very low value (in mm Hg) of 23.079.7 as compared to 62.979.8 in the untreated controls (Po0.001). However, L-NIL did not reduce significantly the ICP in the BCNR rats treated with both L-NIL and sildenafil (65.9713.3) compared with the sildenafil only treated BCNR rats (69.5710.8).
iNOS long-term inhibition caused also a significant reduction of the SMC/collagen ratio in the sildenafil-untreated BCNR rats, to 0.0570.003 from 0.0970.006 in the control (Po0.05), in good agreement to the effects of L-NIL on the erectile response to papaverine. However, despite the lack of significant inhibition on the functional effects of sildenafil, L-NIL moderately interfered with sildenafil effects on the SMC/collagen ratio, by reducing this value from 0.1570.01 to 0.1070.006 (Po0.001).
Discussion
These results confirm and extend our previous work with vardenafil in BCNR rats by showing that UCNR is per se deleterious to the corpora tissue, resulting in a reduction in the SMC content, and SMC proliferation, while increasing collagen content, TGFb1, apoptosis and iNOS induction, to nearly the same extent as BCNR. 33 In addition, the only parameters that UCNR affected significantly less than BCNR were CVOD and collagen deposition thereby suggesting that a certain level of collagen Cavernosal nerve damage and sildenafil I Kovanecz et al deposition may be necessary to cause a frank CVOD. The PCNA results confirmed our previous contention that there is a basal SMC proliferation occurring in the corpora cavernosa, similarly to what occurs in the arterial media, which is reduced by cavernosal nerve damage. 40 Furthermore, oral continuous Figure 3 Effect of long-term sildenafil treatment on the expression of a-smooth muscle-actin (ASMA) in total penile shaft tissue from rats subjected to bilateral cavernosal nerve resection. Homogenates from total penile shaft tissue were submitted to western blot for ASMA. Top: representative pictures of the gels depicting the ASMA band. Bottom: densitometric analysis. ***Po0.001. Figure 4 Effect of unilateral and bilateral cavernosal nerve resection and long-term sildenafil treatment on the collagen III/I ratio and total collagen content in the rat corpora cavernosa. Adjacent tissue sections to those in Figure 2 were submitted to Picro-Sirius red staining and visualized under polarized light (top micrographs). Frozen penile specimens were used to determine the total collagen content by a hydroxyproline assay (bottom). The micrographs depict representative fields taken at Â 40 with the method of overlapping fields and assembled to represent the whole penis (bar: 500 mm) to show the distribution of collagen I (red/orange) and collagen III (greengreenish-yellow), and the bar plots show the quantitative image analysis. A: sham-operated rats; B: untreated unilateral cavernosal nerve resection (UCNR); C: UCNR with sildenafil; D: untreated bilateral cavernosal nerve resection (BCNR); E: BCNR with sildenafil. *Po0.05; **Po0.01 ***Po0.001.
Cavernosal nerve damage and sildenafil I Kovanecz et al long-term treatment with sildenafil, as opposed to the sporadic on demand treatment that is used to elicit an erection, normalized the physiological and for the most part the tissue composition values in the BCNR rats. And finally, as seen with vardenafil, the continuous long-term treatment with sildenafil did not cause noticeable adverse side effects. Moreover, a prolonged treatment with sildenafil in the rat does not induce tachyphylaxis by PDE5 upregulation. 41 Because UCNR and BCNR represent from an experimental point of view what may result from either a partial or complete cavernosal nerve injury, respectively, during a radical prostatectomy, these observations together with those previously shown with vardenafil support the continuous use of oral PDE5 inhibitors post-prostatectomy for preventing the histological changes in the corpora that CVOD and resultant erectile dysfunction. The dose that we have used in this present study is likely to be considered excessive for routine clinical use, since it is roughly equivalent to 200 mg day À1 for men.
12,38
However, we chose this dose based on a parallel study in the aged rat where sildenafil was given in a similar continuous and long-term manner to prevent the histological and physiological changes associated with aging related erectile dysfunction which has been shown to be primarily due to CVOD.
12
This 20 mg kg À1 day À1 dose of sildenafil in the rat is about 10-fold higher than the one we used for vardenafil in our BCNR rat model and is within the dosages that have been tested in continuous administration in experimental animals and even in patients for conditions such as pulmonary hypertension. 33, [42] [43] [44] With the exception of the anti-apoptotic effect that we found with sildenafil in the current study which we did not see with vardenafil in our previous report, both drugs elicited the same effects despite the difference in dosage. 33 Therefore, it is likely that a lower dose of sildenafil would also be as effective. Obviously, a dose response study should be explored in this experimental nerve resection model using retrolingual daily doses, although the pharmacokinetics of sildenafil clearance may require a higher dose. Cavernosal nerve damage and sildenafil I Kovanecz et al Based on these current findings in the UCNR and BCNR models with sildenafil and those previously with vardenafil in the BCNR model, together with that observed in the aged rat treated with sildenafil, we believe that the PDE5 inhibitors possess antifibrotic activity which in the penile tissue may lead to the prevention or delay in the onset or progression of CVOD regardless of its etiology. 33, 12 Although cGMP was not estimated in the penile tissue in this study because the rats were killed after a 24 h washout, we assume that the high cGMP levels generated by PDE5 inhibitors are what counteracts fibrosis and protects the corporal smooth muscle. 12, 33, 37, 38 This assumption is based on the known inhibitory effects of cGMP on collagen synthesis and the TGFb1 pathway, and its vasculoprotective effects on arterial SMC. [14] [15] [16] [17] 20, [45] [46] [47] However, the anti-apoptotic and pro-proliferative effects of sildenafil that we found in the corporal smooth muscle do not agree with the fact that cGMP inhibits vascular SMC proliferation. 48, 49 Since the effects of BCNR on the corporal histology and pharmacokinetics are the same as those seen in the aged rat, we assume that cGMP effects on corporal SMC may be modulated by some specific features in the corporal SMC themselves or the tissue milieu, that are not operative in the vascular SMC. 12 Another still unresolved question is the role of iNOS induction in corporal atrophy after cavernosal nerve damage. Studies on liver and kidney fibrosis in the iNOS knock-out mouse, and our previous work in Peyronie's disease and its animal models, vaginal fibrosis, aging-related arterial media fibrosis, and in corporal fibrosis, suggests that despite iNOS may be initially induced during an early inflammatory process, its main role is as an antifibrotic agent. 12, 13, [24] [25] [26] [27] [28] [29] 32, 33, 37, 38, 50 This may occur via cGMP produced by the nitric oxide from iNOS, and/or the nitric oxide can directly reduce collagen synthesis, myofibroblast formation in the interstitial connective tissue, and reactive oxygen species. 26, [30] [31] [32] In contrast to our study with vardenafil in the BCNR rat, the slight stimulation of iNOS induction by sildenafil in the BCNR animals was not significant.
It is noteworthy that the high iNOS levels in the presence of sildenafil did not counteract the normalization of the apoptotic index or the upregulation of cell replication exerted by the drug. Since nitric oxide in the vasculature is usually pro-apoptotic and antiproliferative, this would support our assumption regarding the opposite response of corporal and arterial SMC toward the nitric oxide/cGMP pathway, in this respect. The experiment using long-term continuous L-NIL as an iNOS inhibitor supported the view that iNOS acts as a true endogenous antifibrotic agent in the BCNR model, as it was in the aged rat. 29 However, the protective effects of longterm continuous sildenafil on restoring erectile function and reducing corporal fibrosis in this model do not seem be mainly mediated by iNOS induction, since L-NIL did not significantly affect the functional response to sildenafil, and interfered only partially with the improvement of the SMC/collagen ratio exerted by the PDE5 inhibitor.
We acknowledge that since this work, as well as the preceding one with vardenafil, has focused on SMC number and fibrosis, we cannot exclude that sildenafil action may also involve protecting the SMC relaxation/contractile phenotype and/or the integrity of the cavernosal endothelium, but we believe the intracellular/extracellular composition of the corporal smooth muscle is the main target of this drug when given long-term, since this balance is responsible for tissue compliance to relaxation by nitric oxide. 33, [51] [52] [53] [54] [55] 
